As GSK and Sanofi promise to produce a Covid-19 vaccine at Indy 500 speed, some experts start to push back on timelines
GlaxoSmithKline and Sanofi turned a few heads today as the two giant vaccine rivals joined hands and technologies as they set off on what they promised would be a lightning-fast development program for a new Covid-19 vaccine — something billions of people around the world have been devoutly praying for.
But this latest promise to move mountains and do something that would have been widely considered impossible just 2 months ago is beginning to garner some pushback from skeptics who believe these players are probably making promises they can’t keep.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 83,000+ biopharma pros reading Endpoints daily — and it's free.